Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-08
1999-06-29
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549283, 549378, A61K 3135, C07D31102, C07D31912
Patent
active
059169141
ABSTRACT:
This invention relates to compounds that are antagonists of dopamine D4 receptors, and to methods of treating psychosis and schizophrenia using a compound that is an antagonist of dopamine D4 receptors.
REFERENCES:
patent: 2547365 (1951-04-01), Bock et al.
patent: 2599001 (1952-06-01), Kerwin et al.
patent: 3154581 (1964-10-01), Dice
patent: 3159676 (1964-12-01), Spickett et al.
patent: 3192253 (1965-06-01), Boscott et al.
patent: 3663712 (1972-05-01), Schmelling et al.
patent: 4010280 (1977-03-01), Maruyama et al.
patent: 5760050 (1998-06-01), Connor et al.
J. Augstein, et al., J Med Chem, "Some Cardiovascular Effects of a Series of Aryloxyalkylamines," 1965, 8, 356.
L.H. Smith, et al, J Med Chem, ".beta.-Adrenergic Blocking Agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-Alkoxyalkylamino-3-phenoxy-2-propanols," 1977, 20:12, 1653-1656.
Connor David Thomas
Johnson Stephen Joseph
Kesten Suzanne Ross
Miller Steven Robert
Unangst Paul Charles
Crissey Todd M.
Murray Joseph
Richter Johann
Warner-Lambert & Company
LandOfFree
Compounds and method of treating psychosis and schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and method of treating psychosis and schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and method of treating psychosis and schizophrenia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1375688